In searching for new molecular targets for bile duct cancer diagnosis and therapy, we found that the receptor tyrosine kinase AXL is highly expressed in bile duct cancer cells and that inhibition of its expression and signaling significantly reduces tumor growth and the spread of cancer cells. Here, AXL is linked to neoplasm.